The Patent Finder

Cytomx Therapeutics, Inc.

Also on record
Records under this name other than the patents Cytomx Therapeutics, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 78 patents it holds.

Back to Cytomx Therapeutics, Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 9,255,155Antibodies Specific for Urokinase-Type Plasminogen Activator and Methods of Treating Cancer
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,952,427ANTI-CD40 Antibodies and Uses Thereof
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,220,544Anti-CD166 antibodies and uses thereof
Lapsed on the fee record
Ended Jan 11, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 11, 2026USPTO record
US 9,856,314Activatable antibodies having non-binding steric moieties and methods of using the same
Lapsed on the fee record
Ended Jan 2, 2026 · USPTO record
Lapsed on the fee recordEnded Jan 2, 2026USPTO record
US 11,174,316ANTI-PDL1 Antibodies, Activatable ANTI-PDL1 Antibodies, and Methods of Use Thereof
Lapsed on the fee record
Ended Nov 16, 2025 · High confidence
Lapsed on the fee recordEnded Nov 16, 2025High confidence
US 11,168,144Activatable anti-PDL1 antibodies, and methods of use thereof
Lapsed on the fee record
Ended Nov 9, 2025 · USPTO record
Lapsed on the fee recordEnded Nov 9, 2025USPTO record
US 8,399,219Protease activatable interferon alpha proprotein
Lapsed on the fee record
Ended Mar 19, 2025 · USPTO record
Lapsed on the fee recordEnded Mar 19, 2025USPTO record
US 10,894,821Activatable antibodies having non-binding steric moieties and methods of using the same
Lapsed on the fee record
Ended Jan 19, 2025 · USPTO record
Lapsed on the fee recordEnded Jan 19, 2025USPTO record
US 10,568,977Antibodies that bind activatable antibodies and methods of use thereof
Lapsed on the fee record
Ended Feb 25, 2024 · USPTO record
Lapsed on the fee recordEnded Feb 25, 2024USPTO record
US 10,513,549Cleavage-activatable interferon-alpha proprotein
Lapsed on the fee record
Ended Dec 24, 2023 · USPTO record
Lapsed on the fee recordEnded Dec 24, 2023USPTO record
10 of 18 patents shown.
Pro members see all 18.
Pro members: see all 18 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited